Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

CompletedOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

April 1, 2015

Study Completion Date

August 1, 2015

Conditions
Sinusitis
Interventions
DEVICE

Balloon sinus dilation

Subjects electing continued medical therapy group will not have balloon sinus dilation intervention. Subjects electing balloon sinus dilation group will have balloon sinus dilation intervention.

DRUG

Medical Management

Subjects who select to continue on medical management rather than have a BSD procedure.

Trial Locations (20)

Unknown

Denver

Miami

Tampa

Atlanta

Savannah

Vidalia

Chicago

Rockford

South Bend

Louisville

Neptune City

Dublin

Frisco

McKinney

Plano

Charlottesville

Norfolk

Richmond

Beaver Dam

Wauwatosa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Acclarent

INDUSTRY

lead

Integra LifeSciences Corporation

INDUSTRY

NCT01685229 - Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter